Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -70,539 | -41,594 | -27,039 | -14,672 | -55,783 |
| Depreciation Amortization | 6,695 | 5,837 | 3,885 | 1,939 | 6,030 |
| Accounts receivable | -5,353 | -6,726 | -5,392 | -3,374 | 6,175 |
| Other Working Capital | -1,730 | -4,498 | -2,531 | -6,340 | -4,413 |
| Other Operating Activity | 37,948 | 22,063 | 15,224 | 8,350 | 2,532 |
| Operating Cash Flow | $-32,979 | $-24,918 | $-15,853 | $-14,097 | $-45,459 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -913 | -380 | -297 | -103 | -517 |
| Investing Cash Flow | $-913 | $-380 | $-297 | $-103 | $-517 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -24,750 |
| Common Stock Issued | 30,123 | 24,668 | 18,581 | 9,891 | 6,215 |
| Other Financing Activity | -14 | -13 | -4 | 0 | 46,992 |
| Financing Cash Flow | $30,109 | $24,655 | $18,577 | $9,891 | $28,457 |
| Beginning Cash Position | 31,807 | 31,807 | 31,807 | 31,807 | 49,326 |
| End Cash Position | 28,024 | 31,164 | 34,234 | 27,498 | 31,807 |
| Net Cash Flow | $-3,783 | $-643 | $2,427 | $-4,309 | $-17,519 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,979 | -24,918 | -15,853 | -14,097 | -45,459 |
| Capital Expenditure | -913 | -380 | -297 | -103 | -517 |
| Free Cash Flow | -33,892 | -25,298 | -16,150 | -14,200 | -45,976 |